Saturday, March 15, 2008 4:02:43 PM
PERIOD ENDING 31-Dec-07 30-Sep-07 30-Jun-07 31-Mar-07
Total Revenue 37,981 27,570 18,580 33,934
Cost of Revenue 15,146 11,159 9,316 12,952
Gross Profit 22,835 16,411 9,264 20,982
Operating Expenses
Research Development 3,081 3,128 3,282 3,364
Selling General and Administrative 7,248 8,213 7,846 8,351
Non Recurring - - - -
Others 1,342 1,329 1,298 1,524
Total Operating Expenses - - - -
Operating Income or Loss 11,164 3,741 (3,162) 7,743
Income from Continuing Operations
Total Other Income/Expenses Net 406 440 526 402
Earnings Before Interest And Taxes 11,570 4,181 (2,636) 8,145
Interest Expense 178 182 193 183
Income Before Tax 11,392 3,999 (2,829) 7,962
Income Tax Expense 3,286 1,579 (1,117) 3,145
Minority Interest - - - -
Net Income From Continuing Ops 8,106 2,420 (1,712) 4,817
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income 8,106 2,420 (1,712) 4,817
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares $8,106 $2,420 ($1,712) $4,817
Recent QDEL News
- Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/19/2024 10:40:00 AM
- QuidelOrtho To Report First Quarter 2024 Financial Results • Business Wire • 04/17/2024 11:00:00 AM
- QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay • Business Wire • 04/10/2024 11:00:00 AM
- QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test • Business Wire • 04/02/2024 01:00:00 PM
- QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada • Business Wire • 03/06/2024 09:35:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:40:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 08:29:59 PM
- QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference • Business Wire • 02/26/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:30:20 PM
- QuidelOrtho Announces Changes in Executive Leadership • Business Wire • 02/21/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:08:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:07:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 12:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:07:22 PM
- QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results • Business Wire • 02/13/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:44:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:43:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:08:22 AM
- QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results • Business Wire • 01/23/2024 12:00:00 PM
- QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/22/2023 12:00:00 PM
- QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay • Business Wire • 12/20/2023 09:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:14:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:40:37 PM
- QuidelOrtho to Participate in the Evercore ISI Conference • Business Wire • 11/16/2023 10:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:12:05 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM